Form 4 Tracker
Christopher R. Cline

CHIEF FINANCIAL OFFICER · 4 filings · Latest: May 4, 2026

Travere Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERMay 6, 2026
Sale
$43.95310$13.6K118,658
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERMay 5, 2026
Sale
$46.652,181$101.7K118,968
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERMay 4, 2026
Option Exercise
$0.004,250121,149
TVTX
CHRISTOPHER CLINEMay 6, 2026
Proposed Sale
$43.95310$13.6K
TVTX
Christopher ClineMay 5, 2026
Proposed Sale
$46.652,181$101.7K
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERApr 15, 2026
Sale
$42.611,014$43.2K116,899
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERApr 14, 2026
Sale
$41.937,248$303.9K117,913
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERApr 13, 2026
Sale
$28.8565$1.9K125,161
TVTX
CHRISTOPHER CLINEApr 15, 2026
Proposed Sale
$42.611,014$43.2K
TVTX
Christopher ClineApr 14, 2026
Proposed Sale
$41.937,239$303.5K
TVTX
CHRISTOPHER CLINEApr 14, 2026
Proposed Sale
$41.079$370
TVTX
Christopher ClineApr 13, 2026
Proposed Sale
$28.8565$1.9K
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERFeb 4, 2026
Sale
$32.191,745$56.2K111,226
TVTX
CHRISTOPHER CLINEFeb 4, 2026
Proposed Sale
$32.191,745$56.2K
TVTX
Christopher ClineFeb 3, 2026
Proposed Sale
$32.127,242$232.6K
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERFeb 3, 2026
Sale
$32.127,242$232.6K112,971
TVTX
CHRISTOPHER CLINEDec 1, 2025
Proposed Sale
$35.0120,000$700.2K
TVTX
Christopher ClineMay 5, 2025
Proposed Sale
$21.051,784$37.6K
TVTX
Christopher ClineApr 11, 2025
Proposed Sale
$13.1448$631
TVTX
Christopher ClineFeb 3, 2025
Proposed Sale
$20.125,192$104.5K